본문 바로가기
KERD
논문KCI 등재

Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice

2

조회

0

다운로드

0

인용

0

참고문헌

초록

Abstract

For treating Leishmania major infection in BALB/c mice, we used thalidomide in conjunction with glucan-time. Groups of mice were challenged with 5 × 103 metacyclic promastigotes of L. majorsubcutaneously. A weekafter the challenge, drug treatment was started and continued for 12 days. Thalidomide was orally administrated 30mg/kg/day and glucantime was administrated intraperitoneally (200 mg/kg/day). It was shown that the combined ther-apy is more effective than single therapies with each one of the drugs since the foot pad swelling in the group of micereceived thalidomide and glucantime was significantly decreased (0.9 ± 0.2 mm) compared to mice treated with eitherglucantime, thalidomide, or carrier alone (1.2 ± 0.25, 1.4 ± 0.3, and 1.7 ± 0.27 mm, respectively). Cytokine studyshowed that the effect of thalidomide was not dependent on IL-12; however, it up-regulated IFN-γand down-regulatedIL-10 production. Conclusively, thalidomide seems promising as a conjunctive therapy with antimony in murine modelof visceral leishmaniasis.

참고문헌 (21)

  1. "Adjuvant Effect of Leishmania majorpromastigotes on the immune response of mice to ovalbumin", 6, pp.123~128 (2002)
  2. "Experimental murine mycobacteriosis: evaluation of the functional activity of alveolar macrophages in Thalidomide-treated mice.", 37, pp.485~492 (2004)
  3. "Experimental Leishmania majorinfection in mice: role of IL-10", 21, pp.211~218 (1999)
  4. "Dissociation of disease susceptibility inflammation andcytokine profile in lmr1", 2 congenic mice infected withLeishmania major, 2004, pp.5, 188~196
  5. "Thalidomide.", 363, pp.1802~1811 (2004)
  6. "Thalidomide and tuberculosis", 6, pp.569~572 (2002)
  7. "Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis", 71, pp.561~567 (2004)
  8. "Leishmaniasis: Current status of vaccine development", 14, pp.229~243 (2001)
  9. "Thalidomide modulation of the immune response in female B6C3F1 mice: a host resistance study", 3, pp.1447~1456 (2003)
  10. "Thalidomide stimulates splenic antibody response and cytotoxic T lymphocyte activity and alters leukocyte subpopulation numbers in female B6C3F1 mice.", 165, pp.237~244 (2000)
  11. "The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB", c mice infected with Leishmania majorby inoculation into the ear dermis depend on the infectiousness and size of the inoculum, 2003, pp.71, 2674~2683
  12. "Thalidomide as an emerging immuno-therapeutic agent Immunol Today 60", 44(1), pp.55~61 (1999)
  13. "Treatment of visceral leishmaniasis a decade of progress and future approaches", 4, pp.158~177 (2000)
  14. "Clinical and experimental advances intreatment of visceral leishmaniasis", 45, pp.2185~2197 (2001)
  15. "Role of endogenous gamma interferon and macrophage microbicidal mecha-nisms in host response to chemotherapy in experimental visceral leishmaniasis.", 68, pp.288~293 (2000)
  16. "Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment", 68, pp.6289~6293 (2000)
  17. "The relative contribution of IL-4 receptor signal-ing and IL-10 to susceptibility to Leishmania major", 170, pp.5152~5158 (2003)
  18. "American cutaneous leish-maniasis: use of a skin test as a predictor of relapse after treatment.", 78, pp.968~974 (2000)
  19. "Analysis of cytokine patterns produced by individual CD4+ lymph node cells during experimental murine leishmaniasis in resis-tant and susceptible mice", 10, pp.1853~1861 (1998)
  20. "Reactivation of latent leishmaniasis by inhibi-tion of inducible nitric oxide synthase.", 183, pp.1501~1514 (1996)
  21. "Response to interferon-gamma plus antimony in Indian visceral leishmaniasis.", 176, pp.1117~1119 (1997)

관련 논문AI추천

Leishmania tropica infection, in comparison toLeishmania major, induces lower delayed type hypersensitivityin BALB/c miceDavood Iravani, Hamid Mahmoudzadeh-Niknam, Simin Sadat Kiaei대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2007 · 제45권 제2호Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasisDavood Iravani, Hamid Mahmoudzadeh-Niknam, Simin Sadat Kiaei대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2007 · 제45권 제4호Anti-leishmanial Effects of Trinitroglycerin in BALB/C Mice Infected with Leishmania major via Nitric Oxide PathwayHabib Nazem, Hossein Nahrevanian, Mahin Farahmand, Mana Najafzadeh, Reza Hajihosseini, Zahra Zamani대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2009 · 제47권 제2호Production of nitric oxide by murine macrophages induced by lipophosphoglycan of Leishmania majorAmina Kariminia, Gholamreza Kavoosi, Sussan K. Ardestani, Zahra Tavakoli대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2006 · 제44권 제1호A Novel Organotellurium Compound (RT-01) as a New Antileishmanial AgentCamila Barbara Cantalupo Lima, Rodrigo Luiz Oliveira Rodrigues Cunha, Selma Giorgio, Wagner Welber Arrais-Silva대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2009 · 제47권 제3호The Route of Leishmania tropica Infection Determines Disease Outcome and Protection against Leishmania major in BALB/c MiceAli Najafy, Firoozeh Abrishami, Ghader Khalili, Hamid Mahmoudzadeh-Niknam, Vahid Khaze대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2013 · 제51권 제1호

이 간행물의 다른 논문 (15건)